Xenon Pharmaceuticals Inc. (XENE)

Xenon Pharmaceuticals, Inc. (XENE) CEO Dr. Simon Pimstone on Q2 2018 Results - Earnings Call Transc
Aug. 11, 2018 | Price: Free! | Source: Seeking Alpha

Xenon Pharmaceuticals' (XENE) CEO Simon Pimstone on Q1 2018 Results - Earnings Call Transcript
May 12, 2018 | Price: Free! | Source: Seeking Alpha

Xenon Pharmaceuticals' (XENE) CEO Simon Pimstone on Q4 2017 Results - Earnings Call Transcript
March 7, 2018 | Price: Free! | Source: Seeking Alpha

Xenon Pharmaceuticals' (XENE) CEO Simon Pimstone on Q2 2017 Results - Earnings Call Transcript
Aug. 6, 2017 | Price: Free! | Source: Seeking Alpha

Xenon Pharmaceuticals' (XENE) CEO Simon Pimstone on Q4 2016 Results - Earnings Call Transcript
March 8, 2017 | Price: Free! | Source: Seeking Alpha

Xenon Pharmaceuticals' (XENE) CEO Simon Pimstone on Q3 2016 Results - Earnings Call Transcript
Nov. 5, 2016 | Price: Free! | Source: Seeking Alpha

Xenon Pharmaceuticals' (XENE) CEO Simon Pimstone on Q2 2016 Results - Earnings Call Transcript
Aug. 5, 2016 | Price: Free! | Source: Seeking Alpha

Xenon Pharmaceuticals' (XENE) CEO Simon Pimstone on Q1 2016 Results - Earnings Call Transcript
May 11, 2016 | Price: Free! | Source: Seeking Alpha

Xenon Pharmaceuticals' (XENE) CEO Simon Pimstone on Q4 2015 Results - Earnings Call Transcript
March 9, 2016 | Price: Free! | Source: Seeking Alpha

Xenon Pharmaceuticals' (XENE) CEO Simon Pimstone on Q3 2015 Results - Earnings Call Transcript
Nov. 10, 2015 | Price: Free! | Source: Seeking Alpha

Xenon Pharmaceuticals' (XENE) CEO Simon Pimstone on Q2 2015 Results - Earnings Call Transcript
Aug. 10, 2015 | Price: Free! | Source: Seeking Alpha

Recent filings

On September - Sept. 13, 2018

Xenon Pharmaceuticals Inc. just filed a prospectus, suggesting it plans to soon issue some securities - Sept. 13, 2018

Xenon Pharmaceuticals Inc. just filed a prospectus, suggesting it plans to soon issue some securities - Sept. 12, 2018

Xenon Pharmaceuticals: Xenon Enters Into Agreement To Buy Out Milestones And Royalties Related To Its Xen1101 Program - Sept. 11, 2018

Confidential treatment order - Sept. 11, 2018

Xenon Pharmaceuticals: Xenon Expands Ion Channel Neurology Pipeline With Addition Of Xen496, A “Phase 3 Ready” Potassium Channel Modulator For The Treatment Of Epilepsy - Sept. 6, 2018

Xenon Pharmaceuticals: Xenon Announces Positive Xen1101 Pharmacodynamic Data From Phase 1B Tms Study - Aug. 29, 2018

Capital World Investors just provided an update on share ownership of Xenon Pharmaceuticals Inc. - Aug. 10, 2018

Xenon Pharmaceuticals Reports Second Quarter 2018 Financial Results And Provides Corporate Update - Aug. 7, 2018

Xenon Pharmaceuticals Inc. Just Filed Its Quarterly Report: 5. Net income ... - Aug. 7, 2018

Statement of acquisition of beneficial ownership by individuals - July 13, 2018

Xenon Pharmaceuticals Inc. just filed a prospectus, suggesting it plans to soon issue some securities - July 12, 2018

Entry into a Material Definitive - July 12, 2018

Phillip Gross just provided an update on share ownership of Xenon Pharmaceuticals Inc. - July 3, 2018

On May - July 3, 2018

Xenon Pharmaceuticals Inc. director just picked up 12,345 shares - June 22, 2018

Xenon Pharmaceuticals Inc. director just picked up 10,288 shares - June 22, 2018

Xenon Pharmaceuticals Inc. director just picked up 5,374 shares - June 15, 2018

Entry into a Material Definitive - June 13, 2018

Capital World Investors just provided an update on share ownership of Xenon Pharmaceuticals Inc. - June 8, 2018

Xenon Pharmaceuticals Inc. director was just granted 15,000 options - June 5, 2018

Xenon Pharmaceuticals Inc. director was just granted 15,000 options - June 5, 2018

Xenon Pharmaceuticals Inc. director was just granted 15,000 options - June 5, 2018

Xenon Pharmaceuticals Inc. director was just granted 15,000 options - June 5, 2018

Xenon Pharmaceuticals Inc. director was just granted 15,000 options - June 5, 2018

Xenon Pharmaceuticals Inc. director was just granted 15,000 options - June 5, 2018

Xenon Pharmaceuticals Inc. director was just granted 15,000 options - June 5, 2018

Xenon Pharmaceuticals Inc. director was just granted 15,000 options - June 5, 2018

Xenon Pharmaceuticals: Xenon Presents Xen901 Phase 1 Clinical Update And Supporting Pre-Clinical Data At 14Th Eilat Conference - May 15, 2018

Xenon Pharmaceuticals Inc. Just Filed Its Quarterly Report: 5. Net income ... - May 8, 2018

Xenon Pharmaceuticals Inc. just filed a prospectus, suggesting it plans to soon issue some securities - May 8, 2018

Mark N. Lampert just provided an update on share ownership of Xenon Pharmaceuticals Inc. - March 29, 2018

Major owner of Xenon Pharmaceuticals Inc. just disposed of 2,437,000 shares - March 29, 2018

Xenon Pharmaceuticals Confirms Closing Of Transaction With Teva And Announces Preferred Share Exchange Agreement With Bvf Partners L.P - March 28, 2018

Xenon Pharmaceuticals Inc.'s Chief Medical Officer was just granted 50,000 options - March 20, 2018

Initial statement of beneficial ownership of securities - March 20, 2018

Xenon Pharmaceuticals Inc. director just picked up 3,086 shares - March 16, 2018

Xenon Pharmaceuticals: American Stock Transfer & Trust Company, Llc Charlotte, North Carolina - March 15, 2018

Xenon Pharmaceuticals Inc.'s CEO just picked up 10,288 shares - March 14, 2018

SVP of Xenon Pharmaceuticals Inc. was just granted 45,000 options - March 13, 2018

Xenon Pharmaceuticals Inc.'s PRESIDENT & CFO was just granted 105,000 options - March 13, 2018

Xenon Pharmaceuticals Inc.'s EVP Bus. & Corp. Development was just granted 55,000 options - March 13, 2018

Dr. Ernesto Aycardi Joins Xenon Pharmaceuticals As Chief Medical Officer - March 13, 2018

Xenon Pharmaceuticals Inc.'s CEO was just granted 140,000 options - March 13, 2018

VP of Xenon Pharmaceuticals Inc. was just granted 40,000 options - March 13, 2018

Xenon Pharmaceuticals Inc. Just Filed Its Annual Report: 5. Net income ... - March 7, 2018

Securities to be offered to employees in employee benefit plans - March 7, 2018

Xenon Pharmaceuticals Reports 2017 Financial Results And Provides Corporate Update - March 7, 2018

Entry into a Material Definitive - March 7, 2018

Xenon Pharmaceuticals Inc. director just disposed of 8,400 shares - March 1, 2018

VP of Xenon Pharmaceuticals Inc. just picked up 4,079 shares - Feb. 14, 2018

Mark N. Lampert just provided an update on share ownership of Xenon Pharmaceuticals Inc. - Feb. 14, 2018

OrbiMed Advisors LLC just provided an update on share ownership of Xenon Pharmaceuticals Inc. - Feb. 13, 2018

Confidential treatment order - Feb. 1, 2018

Xenon Pharmaceuticals Outlines Key Milestones For 2018 - Jan. 8, 2018

Entry into a Material Definitive - Dec. 18, 2017

Xenon Pharmaceuticals Inc. director just picked up 15,000 shares - Nov. 16, 2017

Xenon Pharmaceuticals Inc. Just Filed Its Quarterly Report: 4. Net income ... - Nov. 7, 2017

Xenon Pharmaceuticals Reports Third Quarter 2017 Financial Results And Provides Corporate Update - Nov. 7, 2017

SVP of Xenon Pharmaceuticals Inc. was just granted 20,000 options - Oct. 24, 2017

VP of Xenon Pharmaceuticals Inc. was just granted 11,000 options - Oct. 24, 2017

Xenon Pharmaceuticals Inc.'s CFO & COO was just granted 25,000 options - Oct. 24, 2017

Xenon Pharmaceuticals Inc.'s SVP Bus. & Corp. Development was just granted 11,000 options - Oct. 24, 2017

Xenon Pharmaceuticals Inc.'s President & CEO was just granted 11,000 options - Oct. 24, 2017

SVP of Xenon Pharmaceuticals Inc. was just granted 11,000 options - Oct. 24, 2017

Xenon Pharmaceuticals Inc. director just picked up 10,000 shares - Sept. 25, 2017

Confidential treatment order - Sept. 18, 2017

Confidential treatment order - Sept. 5, 2017

Xenon Pharmaceuticals Inc. director just picked up 6,335 shares - Aug. 21, 2017

Head of Xenon Pharmaceuticals Inc. just picked up 1,000 shares - Aug. 21, 2017

SVP of Xenon Pharmaceuticals Inc. just picked up 10,000 shares - Aug. 17, 2017

Major owner of Xenon Pharmaceuticals Inc. just picked up 60,202 shares - Aug. 16, 2017

Xenon Pharmaceuticals Inc. director just picked up 50,000 shares - Aug. 15, 2017

Xenon Pharmaceuticals Inc. director just picked up 15,000 shares - Aug. 14, 2017

Xenon Pharmaceuticals Inc. director just picked up 7,500 shares - Aug. 14, 2017

Xenon Pharmaceuticals Inc.'s CFO & COO just picked up 15,000 shares - Aug. 14, 2017

Xenon Pharmaceuticals Inc.'s President & CEO just picked up 6,000 shares - Aug. 14, 2017

Xenon Pharmaceuticals Inc. director just picked up 15,000 shares - Aug. 14, 2017

Xenon Pharmaceuticals Inc. director just picked up 7,000 shares - Aug. 14, 2017

Xenon Pharmaceuticals Inc. director just picked up 5,000 shares - Aug. 10, 2017

Xenon Pharmaceuticals Reports Second Quarter 2017 Financial Results And Provides Corporate Update - Aug. 3, 2017

Xenon Pharmaceuticals Inc. Just Filed Its Quarterly Report: 4. Net income ... - Aug. 3, 2017

Major owner of Xenon Pharmaceuticals Inc. just picked up 85,461 shares - June 30, 2017

Major owner of Xenon Pharmaceuticals Inc. just picked up 85,461 shares - June 29, 2017

Xenon Pharmaceuticals: Jerusalem & Burnaby, British Columbia -- June 27, 2017 - June 27, 2017

Major owner of Xenon Pharmaceuticals Inc. just picked up 20,411 shares - June 23, 2017

Xenon Pharmaceuticals Inc. director just cashed-in 1,028 options - June 20, 2017

Major owner of Xenon Pharmaceuticals Inc. just picked up 26,408 shares - June 19, 2017

Major owner of Xenon Pharmaceuticals Inc. just picked up 358,698 shares - June 8, 2017

Xenon Pharmaceuticals Inc. director was just granted 3,500 options - June 2, 2017

Xenon Pharmaceuticals Inc. director was just granted 3,500 options - June 2, 2017

Xenon Pharmaceuticals Inc. director was just granted 3,500 options - June 2, 2017

Xenon Pharmaceuticals Inc. director was just granted 3,500 options - June 2, 2017

Xenon Pharmaceuticals Inc. director was just granted 3,500 options - June 2, 2017

Xenon Pharmaceuticals Inc. director was just granted 4,750 options - June 2, 2017

Xenon Pharmaceuticals Inc. director was just granted 3,500 options - June 2, 2017

Submission of Matters to a Vote of - June 2, 2017

Xenon Pharmaceuticals Inc. director was just granted 3,500 options - June 2, 2017

Xenon Pharmaceuticals Inc.'s SVP Bus. & Corp. Development just picked up 712 shares - May 16, 2017

Xenon Pharmaceuticals: Results Of Operations And Financial Condition - May 9, 2017

Sorry, no schedule available for this company

Owner Shares% of PortfolioAs Of
1. Capital World Investors 1,429,000 N/A Sept. 30, 2017
2. venBio Select Advisor LLC 1,202,118 0.5 June 30, 2018
3. 1,077,241 N/A Dec. 31, 2015
4. ADAGE CAPITAL PARTNERS GP LLC 800,000 N/A June 30, 2018
5. Arnold L. Oronsky 767,187 N/A Dec. 31, 2015
6. Biotechnology Value Fund, L.P. 767,168 N/A March 16, 2016
7. BVF INC/IL 720,830 0.4 March 31, 2018
8. ORBIMED ADVISORS LLC 634,812 0.1 June 30, 2018
9. Granite Point Capital Management, L.P. 482,200 0.3 June 30, 2018
10. Schonfeld Strategic Advisors LLC 455,000 0.2 June 30, 2018
11. Longwood Capital Partners LLC 450,000 0.7 June 30, 2018
12. ROYAL BANK OF CANADA 367,311 N/A Sept. 30, 2016
13. DAFNA Capital Management LLC 294,362 1.3 June 30, 2018
14. RENAISSANCE TECHNOLOGIES LLC 288,000 N/A June 30, 2018
15. Invesco Private Capital, Inc. 248,823 36.6 June 30, 2018
16. Tekla Capital Management LLC 163,819 0.1 June 30, 2018
17. State of New Jersey Common Pension Fund D 155,100 N/A June 30, 2018
18. Artal Group S.A. 150,000 N/A June 30, 2018
19. Knott David M 94,000 0.1 Dec. 31, 2017
20. Point72 Asset Management, L.P. 78,100 N/A June 30, 2018
21. PURA VIDA INVESTMENTS, LLC 75,000 0.4 June 30, 2018
22. SCOTIA CAPITAL INC. 64,357 N/A June 30, 2018
23. CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 55,000 N/A June 30, 2018
24. NJ State Employees Deferred Compensation Plan 50,000 0.1 June 30, 2018
25. JBF Capital, Inc. 40,000 N/A June 30, 2018
26. BOOTHBAY FUND MANAGEMENT, LLC 35,319 N/A June 30, 2018
27. Spark Investment Management LLC 26,100 N/A June 30, 2018
28. KCG Holdings, Inc. 23,367 N/A June 30, 2017
29. OPPENHEIMER FUNDS INC 22,481 N/A June 30, 2018
30. PDT Partners, LLC 17,837 N/A June 30, 2018

Xenon Pharmaceuticals Inc. (XENE)

140
 


Feedback